GluR3B Antibody Was a Biomarker for Drug-Resistant Epilepsy in Patients With Focal to Bilateral Tonic-Clonic Seizures

Considering the role of GluR3B antibody-mediated excitotoxicity in the progression of epilepsy, the purpose of this study was to evaluate the clinical significance of GluR3B antibody level as a novel biomarker for the prognosis of unknown etiology drug-resistant epilepsy (DRE) in patients with focal...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Qingwei, Li, Qingyun, Li, Xinyu, Wang, Heng, Zhang, Wei, Song, Xiaotao, Hu, Peng, Yao, Ruiqin, Fan, Hongbin, Xu, Xingshun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9018978/
https://www.ncbi.nlm.nih.gov/pubmed/35464426
http://dx.doi.org/10.3389/fimmu.2022.838389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9018978/
https://www.ncbi.nlm.nih.gov/pubmed/35464426
http://dx.doi.org/10.3389/fimmu.2022.838389

Ejemplares similares